-- Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q1 Loss $-0.23
4:18PM ET 5/02/2022 MT Newswires...
Arca Biopharma (ABIO) said Monday its board formed a special committee of directors to study potential strategic options to maximize stockholder value. ...
(Corrects to show correct name of Sage's drug candidate in third paragraph.) Health care stocks added to their midday gains this afternoon, with the NYSE...
Health care stocks added to their midday gains this afternoon, with the NYSE Health Care Index rising 0.6% while the SPDR Health Care Select Sector ETF...
Health care stocks were edging higher this afternoon, with the NYSE Health Care Index rising 0.2% while the SPDR Health Care Select Sector ETF (XLV) was up...
ARCA biopharma (ABIO) said late Thursday its phase 2b trial evaluating the lower and higher doses of rNAPc2 for the potential treatment of hospitalized...
Sellas Life Sciences (SLS) shares slumped 25% after the company priced a $25 million public offering. Nuvve (NVVE) shares tumbled 20% after the company...
ARCA biopharma (ABIO) said Thursday it has completed enrollment in the phase 2b clinical study evaluating rNAPc2 small recombinant protein as a potential...
Health care stocks were muted ahead of the opening bell on Friday. The Health Care SPDR (XLV) was flat while the iShares NASDAQ Biotechnology Index (IBB)...